Hanall Biopharma Company Overview

  • Founded
  • 1973
Founded
  • Status
  • Public
  • Employees
  • 310
Employees
  • Stock Symbol
  • 009420
Stock Symbol
  • Investments
  • 3
  • Share Price
  • $22.42
  • (As of Wednesday Closing)

Hanall Biopharma Company General Information

Description

Hanall Biopharma Co Ltd is a part of the healthcare sector. It is one of Korea's leading pharmaceutical companies and is focused on drug delivery, biotherapeutics, and new small molecule discovery. The company's scope comprises of ophthalmology, immunology, cardiovascular treatment and dermatology.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Delivery
Other Industries
Other Pharmaceuticals and Biotechnology
Stock Exchange
KRX
Primary Office
  • 6th Fl., I-Space Building, 11-10
  • Sincheon-Dong
  • Songpa-Gu, 138-922
  • South Korea
+49 08222 0000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Hanall Biopharma Company Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$22.42 $21.62 $18.74 - $37.30 $1.11B 51.2M 717K $0.33

Hanall Biopharma Company Financials Summary

In Thousands,
USD
TTM 31-Dec-2020 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 1,676,628 1,676,628 1,521,868 1,576,713
Revenue 75,042 75,042 93,006 83,558
EBITDA 16,931 16,931 15,473 3,698
Net Income 16,740 16,740 16,444 3,003
Total Assets 201,786 201,786 165,221 145,134
Total Debt 506 506 491 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Hanall Biopharma Company Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Hanall Biopharma Company‘s full profile, request access.

Request a free trial

Hanall Biopharma Company Executive Team (3)

Name Title Board Seat Contact Info
Sung-Yon Lim Director, Finance Planning Division
SeungKook Park Ph.D Executive Vice President & Head, Research
You’re viewing 2 of 3 executive team members. Get the full list »

Hanall Biopharma Company Board Members (1)

Name Representing Role Since
00000000 000 Hanall Biopharma Company Founder & Chairman 000 0000
To view Hanall Biopharma Company’s complete board members history, request access »

Hanall Biopharma Company Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hanall Biopharma Company Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Hanall Biopharma Company‘s full profile, request access.

Request a free trial

Hanall Biopharma Company Investments (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000 19-Jul-2019 00000 00000 00 000.00 Biotechnology
000000000 05-Feb-2016 00000 00000 00 00.00 Biotechnology 0000-000 000
ImmunoMet 01-Aug-2015 Seed Round 00000 Biotechnology 0000-000 000
To view Hanall Biopharma Company’s complete investments history, request access »